Filana Therapeutics, Inc.

FLNA ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011 FY2010
Assets
Cash & Equivalents $10.5M $16.6M $31.3M $40.6M $48.6M $49.4M $73.1M $4.8M
Accounts Receivable — — — — — — — $7.1M
Inventory — — — — — — — —
Total Current Assets $10.7M $19.1M $31.7M $40.8M $50.1M $56.5M $98.5M $98.5M
Property, Plant & Equipment $156.0K $232.0K $215.0K $65.0K — — $122.0K $285.0K
Goodwill — — — — — — — —
Intangible Assets (Excl. Goodwill) — — — — — — — —
Total Assets $10.8M $19.3M $31.9M $40.9M $50.1M $56.9M $99.0M $99.2M
Liabilities
Accounts Payable $424.0K $303.0K $1.0M $173.0K $445.0K $361.0K $464.0K $1.1M
Total Current Liabilities $1.1M $665.0K $2.6M $850.0K $1.8M $10.0M $13.3M $14.1M
Long-Term Debt — — — — — — — —
Total Liabilities $1.1M $665.0K $2.6M $850.0K $1.8M $43.7M $54.6M $66.3M
Stockholders' Equity
Retained Earnings $-157.4M $-145.5M $-130.6M $-116.5M $-104.1M $-135.7M $-132.2M $-129.6M
Total Stockholders' Equity $9.7M $18.6M $29.4M $40.1M $48.3M $13.1M $44.4M $32.9M
← Newer Page 2 of 2 Older →